A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab

Clinical trial NCT05388474 · COMPLETED

Trial details

NCT number: NCT05388474
Sponsor: Theratechnologies
Status: COMPLETED
Study type: OBSERVATIONAL

HIV Infections Multi-Antiviral Resistance

Start date: 2022-03-22
Primary completion: 2026-07-02
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.